These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 34866136)
101. Intention to Inform Relatives, Rates of Cascade Testing, and Preference for Patient-Mediated Communication in Families Concerned with Hereditary Breast and Ovarian Cancer and Lynch Syndrome: The Swiss CASCADE Cohort. Sarki M; Ming C; Aissaoui S; Bürki N; Caiata-Zufferey M; Erlanger TE; Graffeo-Galbiati R; Heinimann K; Heinzelmann-Schwarz V; Monnerat C; Probst-Hensch N; Rabaglio M; Zürrer-Härdi U; Chappuis PO; Katapodi MC; On Behalf Of The Cascade Consortium Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406409 [TBL] [Abstract][Full Text] [Related]
102. No April fools in clinical genomics. McNeill A Eur J Hum Genet; 2022 Apr; 30(4):389-390. PubMed ID: 35393563 [No Abstract] [Full Text] [Related]
103. Cascade screening in HBOC and Lynch syndrome: guidelines and procedures in a UK centre. Evans DG; Green K; Burghel GJ; Forde C; Lalloo F; Schlecht H; Woodward ER Fam Cancer; 2024 Jun; 23(2):187-195. PubMed ID: 38478259 [TBL] [Abstract][Full Text] [Related]
105. Identification of novel pathogenic MSH2 mutation and new DNA repair genes variants: investigation of a Tunisian Lynch syndrome family with discordant twins. Jaballah-Gabteni A; Tounsi H; Kabbage M; Hamdi Y; Elouej S; Ben Ayed I; Medhioub M; Mahmoudi M; Dallali H; Yaiche H; Ben Jemii N; Maaloul A; Mezghani N; Abdelhak S; Hamzaoui L; Azzouz M; Boubaker S J Transl Med; 2019 Jun; 17(1):212. PubMed ID: 31248416 [TBL] [Abstract][Full Text] [Related]
106. Screening for germline mutations of MLH1, MSH2, MSH6 and PMS2 genes in Slovenian colorectal cancer patients: implications for a population specific detection strategy of Lynch syndrome. Berginc G; Bracko M; Ravnik-Glavac M; Glavac D Fam Cancer; 2009; 8(4):421-9. PubMed ID: 19526325 [TBL] [Abstract][Full Text] [Related]
107. Quantification of sequence exchange events between PMS2 and PMS2CL provides a basis for improved mutation scanning of Lynch syndrome patients. van der Klift HM; Tops CM; Bik EC; Boogaard MW; Borgstein AM; Hansson KB; Ausems MG; Gomez Garcia E; Green A; Hes FJ; Izatt L; van Hest LP; Alonso AM; Vriends AH; Wagner A; van Zelst-Stams WA; Vasen HF; Morreau H; Devilee P; Wijnen JT Hum Mutat; 2010 May; 31(5):578-87. PubMed ID: 20186688 [TBL] [Abstract][Full Text] [Related]
108. 30 year experience of index case identification and outcomes of cascade testing in high-risk breast and colorectal cancer predisposition genes. Woodward ER; Green K; Burghel GJ; Bulman M; Clancy T; Lalloo F; Schlecht H; Wallace AJ; Evans DG Eur J Hum Genet; 2022 Apr; 30(4):413-419. PubMed ID: 34866136 [TBL] [Abstract][Full Text] [Related]
109. Identification of Lynch Syndrome. Maratt JK; Stoffel E Gastrointest Endosc Clin N Am; 2022 Jan; 32(1):45-58. PubMed ID: 34798986 [TBL] [Abstract][Full Text] [Related]
110. Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications. Bonis PA; Trikalinos TA; Chung M; Chew P; Ip S; DeVine DA; Lau J Evid Rep Technol Assess (Full Rep); 2007 May; (150):1-180. PubMed ID: 17764220 [TBL] [Abstract][Full Text] [Related]
111. Importance of PCR-based Tumor Testing in the Evaluation of Lynch Syndrome-associated Endometrial Cancer. Bruegl AS; Kernberg A; Broaddus RR Adv Anat Pathol; 2017 Nov; 24(6):372-378. PubMed ID: 28820751 [TBL] [Abstract][Full Text] [Related]